Febuxostat

the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More

Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia

Tigulixostat (IBI128) vs Febuxostat in Gout

The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness

Effect of Dotinurad in Hyperuricemia With Hypertension

A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease

A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout

A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects

Study on the Efficacy and Safety of Thermotherapy in the Treatment of Refractory Gout

Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine

Effect of Allopurinol and Febuxostat on Urinary 2,8-Dihydroxyadenine Excretion

Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome

A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout

Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults

Hyperuricemia and Diabetic Nephropathy

Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients

Role of Uralyt-U in Patients With Hyperuricemia

Uric Acid Effects on Endothelium and Oxydative Stress

Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure